Alle aktuellen medizinischen Publikationen von Prof. Dr. med. Fritschka aus Bad Brückenau
Bei Fragen zu den Artikeln steht Ihnen Prof. Dr. med. Fritschka gerne jederzeit persönlich zur Verfügung.
1: Fritschka E. Gliflozine auch sinnvoll bei dekompensierter Herzinsuffizienz.
MMW Fortschr Med. 2021 Mar;163(Suppl 1):20-21. German. doi:
10.1007/s15006-021-9895-6. PMID: 33950435.
2: Fritschka E. Diabetes begünstigt Nierenversagen bei COVID-19-Patienten :
Corona-Pandemie -- Autor: E. Fritschka. MMW Fortschr Med. 2020 Oct;162(18):31.
German. doi: 10.1007/s15006-020-4481-x. PMID: 33074500; PMCID: PMC7570407.
3: Fritschka E. Typ-2-Diabetes: So kündigen sich mikrovaskuläre Komplikationen
an. MMW Fortschr Med. 2011 Jun;153(23):28. German. doi: 10.1007/BF03368519.
4: Fritschka E. Intensive Zuckersenkung wirkt nicht nach. MMW Fortschr Med. 2019
Nov;161(20):40. German. doi: 10.1007/s15006-019-1120-5. PMID: 31773604.
5: Fritschka E. Diabetiker-RR nach ACS behutsam senken. MMW Fortschr Med. 2019
Feb;161(2):32. German. doi: 10.1007/s15006-019-0123-6. PMID: 30721499.
6: Strobel ES, Fritschka E. Hereditary premenopausal breast cancer. Onkologie.
2002 Feb;25(1):24-7. doi: 10.1159/000055198. PMID: 11893879.
7: Fritschka E, Distler A. Hochdrucktherapie im Alter [Treatment of hypertension
in the aged]. Fortschr Med. 1989 Oct 30;107(31):662-6. German. PMID: 2687141.
8: Fritschka E. ASS für die kardiovaskuläre Prävention? MMW Fortschr Med. 2016
Jan;158(1):30. German. doi: 10.1007/s15006-016-7693-3. PMID: 28924773.
9: Fritschka E. Schwere Hypoglykämien erhöhen die Mortalität. MMW Fortschr Med.
2016 Nov;158(Suppl 3):46. German. doi: 10.1007/s15006-016-8956-8. PMID:
10: Fritschka E. BMI in der Jugend sagt späteres KHK- und Diabetesrisiko voraus.
MMW Fortschr Med. 2011 Oct;153(41):26. German. doi: 10.1007/BF03368891. PMID:
11: Fritschka E, Bönner G. Beratung für reiselustige Hypertoniker. Damit der
Blutdruck nicht in ungesunde Höhen klettert [The travelling patient with
arterial hypertension]. MMW Fortschr Med. 2008 Nov 6;150(45):42-4. German. doi:
10.1007/BF03365659. PMID: 19058390.
12: Strobel ES, Fritschka E. Renal diseases in ankylosing spondylitis: review of
the literature illustrated by case reports. Clin Rheumatol. 1998;17(6):524-30.
doi: 10.1007/BF01451293. PMID: 9890685.
13: Strobel ES, Fritschka E. Case report and review of the literature. Fatal
pulmonary complication in ankylosing spondylitis. Clin Rheumatol. 1997
Nov;16(6):617-22. doi: 10.1007/BF02247804. PMID: 9456016.
14: Fritschka E. Tierisches Fett begünstigt Mikroalbuminurie. MMW Fortschr Med.
2010 Aug;152(36):22. German. doi: 10.1007/BF03366966. PMID: 27369561.
15: Schumann V, Fritschka E, Helmchen U, Wagner K, Philipp T. Interstitielle
Nephritis bei Fleckfieber [Interstitial nephritis in typhus]. Dtsch Med
Wochenschr. 1993 Jun 18;118(24):893-7. German. doi: 10.1055/s-2008-1059401.
16: Sabariego C, Grill E, Brach M, Fritschka E, Mahlmeister J, Stucki G.
Incremental cost-effectiveness analysis of a multidisciplinary renal education
program for patients with chronic renal disease. Disabil Rehabil.
2010;32(5):392-401. doi: 10.3109/09638280903171584. PMID: 20095953.
17: Fritschka E. Diabetes wirkt als BNP-Booster [Diabetes acts as BNP booster.
]. MMW Fortschr Med. 2013 Sep 26;155(16):31. German. doi:
10.1007/s15006-013-2163-7. PMID: 24279149.
18: Philipp T, Kribben A, Fritschka E. Therapie des Shy-Drager-Syndroms
[Treatment of the Shy-Drager syndrome]. Dtsch Med Wochenschr. 1985 Dec
13;110(50):1942-3. German. doi: 10.1055/s-2008-1069118. PMID: 4075989.
19: Thürmann PA, Harder S, Wolter K, Münck AC, Fritschka E. Pharmacokinetics of
the PDGF-antagonist trapidil in patients with and without renal impairment. Clin
Nephrol. 1997 Feb;47(2):99-105. PMID: 9049457.
20: Fritschka E, Distler A. Was heisst "gute Blutdruckeinstellung"? [What does
"good blood pressure regulation" mean?]. Med Klin (Munich). 1988 Sep
2;83(17):571-4. German. PMID: 3050417.
21: Kribben A, Fritschka E, Sibold M, Fassbender M, Rothschild M, Distler A,
Philipp T. Different effects of furosemide on alpha-adrenoceptors and on
platelet aggregation in man. Klin Wochenschr. 1988 Jul 15;66(14):624-7. doi:
10.1007/BF01728803. PMID: 2850406.
22: Wolter K, Claus M, Fritschka E. Pharmacokinetics and dosage recommendations
of teicoplanin in patients treated by continuous veno-venous haemodialysis
(CVVHD). Eur J Clin Pharmacol. 1994;46(2):179-80. doi: 10.1007/BF00199886. PMID:
23: Shigeno T, Brock M, Shigeno S, Fritschka E, Cervós-Navarro J. The
determination of brain water content: microgravimetry versus drying-weighing
method. J Neurosurg. 1982 Jul;57(1):99-107. doi: 10.3171/jns.1982.57.1.0099.
24: Vogel HP, Kroll M, Fritschka E, Quabbe HJ. Twenty-four-hour profiles of
growth hormone, prolactin and cortisol in the chronic vegetative state. Clin
Endocrinol (Oxf). 1990 Nov;33(5):631-43. doi:
10.1111/j.1365-2265.1990.tb03902.x. PMID: 2253414.
25: Rahn KH, Barenbrock M, Fritschka E, Heinecke A, Lippert J, Schroeder K,
Hauser I, Wagner K, Neumayer HH. Effect of nitrendipine on renal function in
renal-transplant patients treated with cyclosporin: a randomised trial. Lancet.
1999 Oct 23;354(9188):1415-20. doi: 10.1016/S0140-6736(99)08421-4. PMID:
26: Wolter K, Fritschka E. Pharmacokinetics and pharmacodynamics of quinaprilat
after low dose quinapril in patients with terminal renal failure. Eur J Clin
Pharmacol. 1993;44 Suppl 1:S53-6. doi: 10.1007/BF01428395. PMID: 8387427.
27: Fritschka E, Neumayer HH, Seddighi S, Thiede HM, Distler A, Philipp T.
Effect of erythropoietin on parameters of sympathetic nervous activity in
patients undergoing chronic haemodialysis. Br J Clin Pharmacol. 1990;30 Suppl
1(Suppl 1):135S-138S. doi: 10.1111/j.1365-2125.1990.tb05485.x. PMID: 2176518;
28: Fritschka E, Gotzen R, Kittler R, Schöneshöfer M. Effect of metoprolol on
24-hour urinary excretion of adrenal steroids and kallikrein in patients with
essential hypertension. Br J Pharmacol. 1984 Feb;81(2):245-53. doi:
10.1111/j.1476-5381.1984.tb10071.x. PMID: 6367871; PMCID: PMC1986883.
29: Stumpe KO, Agabiti-Rosei E, Zielinski T, Schremmer D, Scholze J, Laeis P,
Schwandt P, Ludwig M; MORE study investigators. Carotid intima-media thickness
and plaque volume changes following 2-year angiotensin II-receptor blockade. The
Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther
Adv Cardiovasc Dis. 2007 Dec;1(2):97-106. doi: 10.1177/1753944707085982. PMID:
30: Kribben A, Bremer C, Fritschka E, Koeppen S, Ahrens O, Philipp T. Ambulatory
infusion of noradrenaline for long-term treatment of Shy-Drager syndrome. Kidney
Blood Press Res. 1998;21(1):70-3. doi: 10.1159/000025846. PMID: 9661140.
31: Wolter K, Wagner K, Philipp T, Fritschka E. Interaction between FK 506 and
clarithromycin in a renal transplant patient. Eur J Clin Pharmacol.
1994;47(2):207-8. doi: 10.1007/BF00194974. PMID: 7532134.
32: Wolter K, Marggraf G, Dermoumi H, Fritschka E. Elimination of fluconazole
during continuous veno-venous haemodialysis (CVVHD) in a single patient. Eur J
Clin Pharmacol. 1994;47(3):291-2. doi: 10.1007/BF02570511. PMID: 7867684.
33: Strobel ES, Fritschka E, Schmitt-Gräff A, Peter HH. An unusual case of
systemic lupus erythematosus, lupus nephritis, and transient monoclonal
gammopathy. Rheumatol Int. 2000;19(6):235-41. doi: 10.1007/pl00006855. PMID:
34: Strobel ES, Fritschka E. Onkologische Rehabilitation. So finden
Krebspatienten in den Alltag zurück [Current aspects of oncological
rehabilitation]. MMW Fortschr Med. 2006 Oct 19;148(42):49-51. German. PMID:
35: Strobel ES, Fritschka E, Schimke E, Schmolke B. Differentialdiagnose Makro-
CK Typ 1 bei thorakalen Schmerzen und erhöhter CK-MB [Differential Diagnosis
Macro CK Type 1 in Thoracic Pain Syndrome and Increased CK-MB]. Med Klin
(Munich). 2003 Oct 15;98(10):583-6. German. doi: 10.1007/s00063-003-1298-1.
36: Fritschka E. Blutdruck bei Demenz nicht zu weit senken [Do not lower blood
pressure too low in dementia]. MMW Fortschr Med. 2015 Nov 19;157(20):41. German.
doi: 10.1007/s15006-015-7557-2. PMID: 26977513.
37: Ludwig M, Stapff M, Ribeiro A, Fritschka E, Tholl U, Smith RD, Stumpe KO.
Comparison of the effects of losartan and atenolol on common carotid artery
intima-media thickness in patients with hypertension: results of a 2-year,
double-blind, randomized, controlled study. Clin Ther. 2002 Jul;24(7):1175-93.
doi: 10.1016/s0149-2918(02)80028-5. PMID: 12182261.
38: Hellinger A, Wolter K, Marggraf G, Pentz R, Fritschka E. Elimination of
amrinone during continuous veno-venous haemofiltration after cardiac surgery.
Eur J Clin Pharmacol. 1995;48(1):57-9. doi: 10.1007/BF00202173. PMID: 7621849.
39: Neumayer HH, Brockmöller J, Fritschka E, Roots I, Scigalla P, Wattenberg M.
Pharmacokinetics of recombinant human erythropoietin after SC administration and
in long-term IV treatment in patients on maintenance hemodialysis. Contrib
Nephrol. 1989;76:131-41; discussion 141-2. doi: 10.1159/000417889. PMID:
40: Fritschka E, Neumayer HH, Seddighi S, Distler A, Philipp T. Einfluss einer
Erythropoetintherapie auf die alpha-Adrenozeptoren-Dichte bei chronischen
Dialysepatienten [Effect of erythropoietin therapy on alpha receptor density in
chronic dialysis patients]. Med Klin (Munich). 1991 Jul 15;86(7):353-9. German.
41: Wolter K, Claus M, Wagner K, Fritschka E. Teicoplanin pharmacokinetics and
dosage recommendations in chronic hemodialysis patients and in patients
undergoing continuous veno-venous hemodialysis. Clin Nephrol. 1994
Dec;42(6):389-97. PMID: 7882603.
42: Rudy T, Hartwig T, Fritschka E, Erhard J, Eigler FW. Monitoring of plasma
endothelin in relation to Doppler signal in human liver transplantation.
Transplant Proc. 1993 Aug;25(4):2658-61. PMID: 8356712.
43: Zotz RB, Fritschka E, Lange R, Erhard J, Beste M, Skworc K, Breuer N.
Erhöhte Plasma-Endothelin-Konzentrationen bei Patienten nach
Lebertransplantation und bei Leberzirrhose [Increased plasma endothelin
concentrations in patients after liver transplantation and in liver cirrhosis].
Med Klin (Munich). 1993 Mar 15;88(3):139-42. German. PMID: 8474403.
44: Aritake K, Mayer HM, Fritschka E, Cervós-Navarro J, Takakura K. [Cerebral
hemodynamics in chronic hypoxic hypoxia]. No To Shinkei. 1986 Apr;38(4):363-9.
45: Shigeno T, Fritschka E, Brock M, Schramm J, Shigeno S, Cervoś-Navarro J.
Cerebral edema following experimental subarachnoid hemorrhage. Stroke. 1982 May-
Jun;13(3):368-79. doi: 10.1161/01.str.13.3.368. PMID: 7080133.
46: Oldenburg O, Erbel R, Fritschka E, Philipp T, Kribben A. Ambulatory
norepinephrine infusion in severe idiopathic orthostatic hypotension (Bradbury
Eggleston syndrome). Cardiovasc Drugs Ther. 1999 Jul;13(4):355-6. doi:
10.1023/a:1007767702091. PMID: 10516872.
47: Kribben A, Fritschka E, Philipp T. Diagnostik des Shy-Drager-Syndroms
[Diagnosis of the Shy-Drager syndrome]. Dtsch Med Wochenschr. 1985 Dec
13;110(50):1940-1. German. doi: 10.1055/s-2008-1069117. PMID: 4075988.
48: Fritschka E, Kribben A, Hoyer J, Rothschild M, Thiede HM, Distler A, Philipp
T. Regulation of alpha 2-adrenoceptor density in normotensive and hypertensive
man. J Hypertens Suppl. 1987 Dec;5(5):S349-52. PMID: 2832574.
49: Shigeno S, Fritschka E, Shigeno T, Brock M. Effects of indomethacin on rCBF
during and after focal cerebral ischemia in the cat. Stroke. 1985 Mar-
Apr;16(2):235-40. doi: 10.1161/01.str.16.2.235. PMID: 3975961.
50: Fritschka E. Comparisons of once-daily nilvadipine with enalapril and
diuretic in patients with essential hypertension. J Cardiovasc Pharmacol.
1992;20 Suppl 6:S62-8. PMID: 1283192.
51: Fritschka E, Ferguson JL, Spitzer JJ. Total and regional cerebral blood flow
during perfusion from the lateral ventricle to the cisterna magna in the
conscious dog: effect of hemorrhagic hypotension and retransfusion on cerebral
blood flow. Circ Shock. 1980;7(3):333-42. PMID: 7449048.
52: Schultz KD, Fritschka E, Kribben A, Rothschild M, Thiede HM, Distler A,
Philipp T. Alpha 2- and beta 2-adrenoceptor downregulation in marathon runners.
J Hypertens Suppl. 1989 Dec;7(6):S48-9. PMID: 2561150.
53: Distler A, Haller H, Harwig S, Kribben A, Lüdersdorf M, Thiede M, Fritschka
E, Philipp T. Sympathetic tone and pressor response to noradrenaline during
mineralocorticoid-induced blood pressure rise in man. J Hypertens Suppl. 1985
Dec;3(4):S27-32. PMID: 3007704.
54: Shigeno T, Fritschka E, Shigeno S, Brock M. Neurogenic shock syndrome after
experimental subarachnoid hemorrhage in cats. Adv Shock Res. 1982;8:135-44.
55: Fritschka E, Schmidt G. Langzeitwirksamkeit und Nebenwirkungsprofil einer
niedrigdosierten Bemetizid-Triamteren-Kombination bei Patienten mit essentieller
Hypertonie [Long-term efficacy and side effect profile of a low-dose bemetizid-
triamterene combination in patients with essential hypertension]. Med Klin
(Munich). 1989 Nov 15;84(11):526-33. German. PMID: 2512474.
56: Fritschka E, Distler A, Lenz T, Kribben A, Schudrowitsch L, Philipp T.
Effect of nifedipine and verapamil on alpha-receptor-activation in patients with
essential hypertension. J Hypertens Suppl. 1984 Dec;2(3):S535-8. PMID: 6100753.
57: Kribben A, Fritschka E, Philipp T, Thiede HM, Distler A. Ambulante
Noradrenalininfusion bei therapieresistentem Shy-Drager-Syndrom [Ambulatory
noradrenaline infusion in refractory Shy-Drager syndrome]. Schweiz Rundsch Med
Prax. 1985 Apr 16;74(16):407-10. German. PMID: 3992100.
58: Kribben A, Fritschka E, Senger D, Sibold M, Distler A, Philipp T. Effects of
nitrendipine and tiapamil on 45Ca2+ influx and on platelet aggregation. J
Cardiovasc Pharmacol. 1987;10 Suppl 10:S68-9. PMID: 2455144.
59: Wagner K, Metz-Kurschel U, Claus M, Fritschka E, Maasche B, Becker G,
Helmchen U, Phillip T. Effect of FK 506 on excretion of urinary enzymes in rats.
Transplant Proc. 1991 Dec;23(6):3126-7. PMID: 1721379.
60: Fritschka E, Distler A, Gotzen R, Thiede HM, Philipp T. Crossover comparison
of nitrendipine with propranolol in patients with essential hypertension. J
Cardiovasc Pharmacol. 1984;6 Suppl 7:S1100-4. PMID: 6085375.
61: Fritschka E, Ferguson JL, Spitzer JJ. Increased free fatty acid turnover in
CSF during hypotension in dogs. Am J Physiol. 1979 Jun;236(6):H802-7. doi:
10.1152/ajpheart.1979.236.6.H802. PMID: 443442.
62: Schultz KD, Fritschka E, Pauliks LB, Philipp T, Distler A. Increased
forskolin stimulation of lymphocyte-adenylate cyclase in normotensive subjects
predisposed to essential hypertension. J Hypertens Suppl. 1989 Dec;7(6):S142-3.
doi: 10.1097/00004872-198900076-00067. PMID: 2632696.
63: Fritschka E, Ferguson JL, Spitzer JJ. Effect of moderate hemorrhagic
hypotension on cerebral metabolism during ventriculocisternal perfusion in the
conscious dog. Adv Shock Res. 1978;1:29-33. PMID: 262087.
64: Fritschka E, Quabbe HJ, Spitzer JJ. Removal of 14-C-palmitate during
ventriculocisternal perfusion in conscious dogs in insulin-induced hypoglycemia.
Brain Res Bull. 1979 May-Jun;4(3):333-8. doi: 10.1016/s0361-9230(79)80010-6.
65: Bönner G, Toussaint C, Claus M, Fritschka E, Philipp T, Vetter H, Feltkamp
H. Lack of oral kallikrein in lowering systemic blood pressure in primary
hypertension. Agents Actions Suppl. 1992;38 ( Pt 3):294-303. PMID: 1462864.
66: Rudy T, Fritschka E, Erhard J, Eigler FW. Langzeitverlauf der Endothelin-
Plasma- und der Interleukin-2-Rezeptor-Serumspiegel nach Lebertransplantation
[Follow-up of plasma endothelin and serum interleukin 2 receptor level after
liver transplantation]. Langenbecks Arch Chir. 1995;380(3):189-93. German. doi:
10.1007/BF00207728. PMID: 7791493.
67: Jockenhövel F, Grandt D, Weber F, Fritschka E, Philipp T. Plasmaaustausch
zur Therapie des rekurrierenden hämolytisch-urämischen Syndroms (HUS) beim
Erwachsenen [Plasma exchange as therapy of recurrent hemolytic-uremic syndrome
(HUS) in adults]. Med Klin (Munich). 1991 Aug 15;86(8):419-22. German. PMID:
Haben Sie Fragen zu den vorgestellten Publikationen oder wünschen einen Behandlungstermin? Rufen Sie uns gerne an.